Review



cell culture primary human adult cardiac fibroblasts  (Cell Applications Inc)


Bioz Verified Symbol Cell Applications Inc is a verified supplier
Bioz Manufacturer Symbol Cell Applications Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Applications Inc cell culture primary human adult cardiac fibroblasts
    Image processing techniques and experimental timeline. (a) Representative raw and thresholded images of nuclei, actin, and α-SMA in untreated and TGF-β1-treated human cardiac <t>fibroblasts</t> (scale bars: 200 μm). (b) Experimental timeline for culturing cardiac fibroblasts with reduced serum and TGF-β1 treatment. (A color version of this figure is available in the online journal.)
    Cell Culture Primary Human Adult Cardiac Fibroblasts, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 93/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell culture primary human adult cardiac fibroblasts/product/Cell Applications Inc
    Average 93 stars, based on 26 article reviews
    cell culture primary human adult cardiac fibroblasts - by Bioz Stars, 2026-05
    93/100 stars

    Images

    1) Product Images from "Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts"

    Article Title: Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts

    Journal: Experimental Biology and Medicine

    doi: 10.1177/1535370218761628

    Image processing techniques and experimental timeline. (a) Representative raw and thresholded images of nuclei, actin, and α-SMA in untreated and TGF-β1-treated human cardiac fibroblasts (scale bars: 200 μm). (b) Experimental timeline for culturing cardiac fibroblasts with reduced serum and TGF-β1 treatment. (A color version of this figure is available in the online journal.)
    Figure Legend Snippet: Image processing techniques and experimental timeline. (a) Representative raw and thresholded images of nuclei, actin, and α-SMA in untreated and TGF-β1-treated human cardiac fibroblasts (scale bars: 200 μm). (b) Experimental timeline for culturing cardiac fibroblasts with reduced serum and TGF-β1 treatment. (A color version of this figure is available in the online journal.)

    Techniques Used:

    Cell morphology and α-SMA expression due to ECM rigidity and TGF-β1 treatment. Representative images of human cardiac fibroblasts cultured for five days on low, moderate, and high PDMS-coated coverslips with or without 2 ng/mL TGF-β1 (blue: nuclei, green: actin, red: α-SMA, scale bars: 25 μm).
    Figure Legend Snippet: Cell morphology and α-SMA expression due to ECM rigidity and TGF-β1 treatment. Representative images of human cardiac fibroblasts cultured for five days on low, moderate, and high PDMS-coated coverslips with or without 2 ng/mL TGF-β1 (blue: nuclei, green: actin, red: α-SMA, scale bars: 25 μm).

    Techniques Used: Expressing, Cell Culture

    Quantification of cell morphology and α-SMA expression due to ECM rigidity and TGF-β1 treatment. Human cardiac fibroblasts were cultured on low, moderate, and high PDMS-coated coated coverslips with or without 2 ng/mL TGF-β1 for one, three, and five days. Cells were immunostained and cell density (a), actin coverage (b), and α-SMA/actin coverage (c) were quantified from immunostained images (n = 4, bars indicate mean ± standard error of the mean, *P < 0.05 and **P < 0.01 according to one-way ANOVA and Tukey’s test for multiple comparisons. For detailed statistical analysis, see Supplementary Tables S2 to S4). (A color version of this figure is available in the online journal.)
    Figure Legend Snippet: Quantification of cell morphology and α-SMA expression due to ECM rigidity and TGF-β1 treatment. Human cardiac fibroblasts were cultured on low, moderate, and high PDMS-coated coated coverslips with or without 2 ng/mL TGF-β1 for one, three, and five days. Cells were immunostained and cell density (a), actin coverage (b), and α-SMA/actin coverage (c) were quantified from immunostained images (n = 4, bars indicate mean ± standard error of the mean, *P < 0.05 and **P < 0.01 according to one-way ANOVA and Tukey’s test for multiple comparisons. For detailed statistical analysis, see Supplementary Tables S2 to S4). (A color version of this figure is available in the online journal.)

    Techniques Used: Expressing, Cell Culture

    Relative changes in gene expression due to ECM rigidity and TGF-β1 treatment. Human cardiac fibroblasts were cultured on low, moderate, and high PDMS-coated coated coverslips with or without 2 ng/mL TGF-β1 for one, three, and five days. RT-PCR was used to quantify the relative expression of (a) ACTA2, (b) POSTN, (c) FAP, (d) FSP1, and (e) GJA1. All data were normalized to high PDMS control group on Day 1. (n = 4, bars indicate mean ±standard error of the mean, *P < 0.05 and **P < 0.01 according to one-way ANOVA and Tukey’s test for multiple comparisons. For detailed statistical analysis, see Supplementary Tables S5 to S9). (A color version of this figure is available in the online journal.)
    Figure Legend Snippet: Relative changes in gene expression due to ECM rigidity and TGF-β1 treatment. Human cardiac fibroblasts were cultured on low, moderate, and high PDMS-coated coated coverslips with or without 2 ng/mL TGF-β1 for one, three, and five days. RT-PCR was used to quantify the relative expression of (a) ACTA2, (b) POSTN, (c) FAP, (d) FSP1, and (e) GJA1. All data were normalized to high PDMS control group on Day 1. (n = 4, bars indicate mean ±standard error of the mean, *P < 0.05 and **P < 0.01 according to one-way ANOVA and Tukey’s test for multiple comparisons. For detailed statistical analysis, see Supplementary Tables S5 to S9). (A color version of this figure is available in the online journal.)

    Techniques Used: Gene Expression, Cell Culture, Reverse Transcription Polymerase Chain Reaction, Expressing, Control



    Similar Products

    93
    Cell Applications Inc cell culture primary human adult cardiac fibroblasts
    Image processing techniques and experimental timeline. (a) Representative raw and thresholded images of nuclei, actin, and α-SMA in untreated and TGF-β1-treated human cardiac <t>fibroblasts</t> (scale bars: 200 μm). (b) Experimental timeline for culturing cardiac fibroblasts with reduced serum and TGF-β1 treatment. (A color version of this figure is available in the online journal.)
    Cell Culture Primary Human Adult Cardiac Fibroblasts, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell culture primary human adult cardiac fibroblasts/product/Cell Applications Inc
    Average 93 stars, based on 1 article reviews
    cell culture primary human adult cardiac fibroblasts - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    Image processing techniques and experimental timeline. (a) Representative raw and thresholded images of nuclei, actin, and α-SMA in untreated and TGF-β1-treated human cardiac fibroblasts (scale bars: 200 μm). (b) Experimental timeline for culturing cardiac fibroblasts with reduced serum and TGF-β1 treatment. (A color version of this figure is available in the online journal.)

    Journal: Experimental Biology and Medicine

    Article Title: Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts

    doi: 10.1177/1535370218761628

    Figure Lengend Snippet: Image processing techniques and experimental timeline. (a) Representative raw and thresholded images of nuclei, actin, and α-SMA in untreated and TGF-β1-treated human cardiac fibroblasts (scale bars: 200 μm). (b) Experimental timeline for culturing cardiac fibroblasts with reduced serum and TGF-β1 treatment. (A color version of this figure is available in the online journal.)

    Article Snippet: Cell culture Primary human adult cardiac fibroblasts (Lot 3131, Cell Applications Inc., San Diego, CA, USA) were thawed into a 75 cm 2 cell culture flask with fibroblast growth medium, consisting of low glucose DMEM (1 g/L glucose) supplemented with 10% v/v fetal bovine serum (FBS) (Gibco, Waltham, MA, USA) and 1% v/v penicillin-streptomycin solution (10,000 U/mL penicillin, 10,000 μg/mL streptomycin).

    Techniques:

    Cell morphology and α-SMA expression due to ECM rigidity and TGF-β1 treatment. Representative images of human cardiac fibroblasts cultured for five days on low, moderate, and high PDMS-coated coverslips with or without 2 ng/mL TGF-β1 (blue: nuclei, green: actin, red: α-SMA, scale bars: 25 μm).

    Journal: Experimental Biology and Medicine

    Article Title: Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts

    doi: 10.1177/1535370218761628

    Figure Lengend Snippet: Cell morphology and α-SMA expression due to ECM rigidity and TGF-β1 treatment. Representative images of human cardiac fibroblasts cultured for five days on low, moderate, and high PDMS-coated coverslips with or without 2 ng/mL TGF-β1 (blue: nuclei, green: actin, red: α-SMA, scale bars: 25 μm).

    Article Snippet: Cell culture Primary human adult cardiac fibroblasts (Lot 3131, Cell Applications Inc., San Diego, CA, USA) were thawed into a 75 cm 2 cell culture flask with fibroblast growth medium, consisting of low glucose DMEM (1 g/L glucose) supplemented with 10% v/v fetal bovine serum (FBS) (Gibco, Waltham, MA, USA) and 1% v/v penicillin-streptomycin solution (10,000 U/mL penicillin, 10,000 μg/mL streptomycin).

    Techniques: Expressing, Cell Culture

    Quantification of cell morphology and α-SMA expression due to ECM rigidity and TGF-β1 treatment. Human cardiac fibroblasts were cultured on low, moderate, and high PDMS-coated coated coverslips with or without 2 ng/mL TGF-β1 for one, three, and five days. Cells were immunostained and cell density (a), actin coverage (b), and α-SMA/actin coverage (c) were quantified from immunostained images (n = 4, bars indicate mean ± standard error of the mean, *P < 0.05 and **P < 0.01 according to one-way ANOVA and Tukey’s test for multiple comparisons. For detailed statistical analysis, see Supplementary Tables S2 to S4). (A color version of this figure is available in the online journal.)

    Journal: Experimental Biology and Medicine

    Article Title: Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts

    doi: 10.1177/1535370218761628

    Figure Lengend Snippet: Quantification of cell morphology and α-SMA expression due to ECM rigidity and TGF-β1 treatment. Human cardiac fibroblasts were cultured on low, moderate, and high PDMS-coated coated coverslips with or without 2 ng/mL TGF-β1 for one, three, and five days. Cells were immunostained and cell density (a), actin coverage (b), and α-SMA/actin coverage (c) were quantified from immunostained images (n = 4, bars indicate mean ± standard error of the mean, *P < 0.05 and **P < 0.01 according to one-way ANOVA and Tukey’s test for multiple comparisons. For detailed statistical analysis, see Supplementary Tables S2 to S4). (A color version of this figure is available in the online journal.)

    Article Snippet: Cell culture Primary human adult cardiac fibroblasts (Lot 3131, Cell Applications Inc., San Diego, CA, USA) were thawed into a 75 cm 2 cell culture flask with fibroblast growth medium, consisting of low glucose DMEM (1 g/L glucose) supplemented with 10% v/v fetal bovine serum (FBS) (Gibco, Waltham, MA, USA) and 1% v/v penicillin-streptomycin solution (10,000 U/mL penicillin, 10,000 μg/mL streptomycin).

    Techniques: Expressing, Cell Culture

    Relative changes in gene expression due to ECM rigidity and TGF-β1 treatment. Human cardiac fibroblasts were cultured on low, moderate, and high PDMS-coated coated coverslips with or without 2 ng/mL TGF-β1 for one, three, and five days. RT-PCR was used to quantify the relative expression of (a) ACTA2, (b) POSTN, (c) FAP, (d) FSP1, and (e) GJA1. All data were normalized to high PDMS control group on Day 1. (n = 4, bars indicate mean ±standard error of the mean, *P < 0.05 and **P < 0.01 according to one-way ANOVA and Tukey’s test for multiple comparisons. For detailed statistical analysis, see Supplementary Tables S5 to S9). (A color version of this figure is available in the online journal.)

    Journal: Experimental Biology and Medicine

    Article Title: Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts

    doi: 10.1177/1535370218761628

    Figure Lengend Snippet: Relative changes in gene expression due to ECM rigidity and TGF-β1 treatment. Human cardiac fibroblasts were cultured on low, moderate, and high PDMS-coated coated coverslips with or without 2 ng/mL TGF-β1 for one, three, and five days. RT-PCR was used to quantify the relative expression of (a) ACTA2, (b) POSTN, (c) FAP, (d) FSP1, and (e) GJA1. All data were normalized to high PDMS control group on Day 1. (n = 4, bars indicate mean ±standard error of the mean, *P < 0.05 and **P < 0.01 according to one-way ANOVA and Tukey’s test for multiple comparisons. For detailed statistical analysis, see Supplementary Tables S5 to S9). (A color version of this figure is available in the online journal.)

    Article Snippet: Cell culture Primary human adult cardiac fibroblasts (Lot 3131, Cell Applications Inc., San Diego, CA, USA) were thawed into a 75 cm 2 cell culture flask with fibroblast growth medium, consisting of low glucose DMEM (1 g/L glucose) supplemented with 10% v/v fetal bovine serum (FBS) (Gibco, Waltham, MA, USA) and 1% v/v penicillin-streptomycin solution (10,000 U/mL penicillin, 10,000 μg/mL streptomycin).

    Techniques: Gene Expression, Cell Culture, Reverse Transcription Polymerase Chain Reaction, Expressing, Control